Bryan Valcarcel, MD^1*, Haruhiko Sano, MD^2*, Hiroo Katsuya, MD, PhD^3*, Atae Utsunomiya, MD⁴, Maki Otsuka, MD^5*, Masaharu Miyahara, MD^6*, Yasushi Takamatsu, MD, PhD^7*, Kenji Ishitsuka, MD, PhD⁸, Shinya Kimura, MD, PhD^2*, Junji Suzumiya, MD, PhD⁹, Kazuo Tamura, MD, PhD^7*, Daniel J Enriquez, MD¹⁰, Denisse Castro, MD¹¹, Brady E Beltran, MD^11*, Henry Idrobo, MD^12*, Camila Peña, MD¹³, Lorena Fiad, MD^14*, Juan Carlos Ramos, MD¹⁵ and Luis Enrique Malpica Castillo, MD¹⁶

¹Milken Institute School of Public Health, The George Washington University, Washington, MD
²Saga University, Saga, Japan
³Saga University, Saga, FKO, Japan
⁴Imamura General Hospital, Kagoshima, Japan
⁵National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
⁶Karatsu Red Cross Hospital, Karatsu, Japan
⁷Fukuoka University, Fukuoka, Japan
⁸Kagoshima University Hospital, Kagoshima, Japan
⁹Koga Community Hospital, Yaizu, Japan
¹⁰Departamento de Oncologia Medica, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
¹¹Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹²Hospital Universitario del Valle, Cali, Colombia
¹³Hematology Department, Hospital Del Salvador, Santiago, Chile
¹⁴Departamento de Hematologia, Hospital Italiano de La Plata, La Plata, Argentina
¹⁵Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
¹⁶Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Supreet Kaur, MD¹, Pankil Shah, MD PhD^2*, Adolfo Enrique Diaz Duque, MD³ and Dimpy P. Shah, MD, PhD^4*

¹UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio
²UT Health, San Antonio, TX
³Hematology-Oncology Division, Associate Professor, San Antonio, TX
⁴Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX

Daniel A. Ermann, MD¹, Victoria A. Vardell, MD², Manasa Velagapudi, MD^3*, Greer Burkholder, MD^4*, Lindsey A. Fitzgerald, MD⁵, Mayur Narkhede, MBBS⁶, Harsh Shah, DO⁷, Lauren Shea^8*, Adam Spivak, MD^9*, Deborah M. Stephens, DO⁷, Boyu Hu, MD⁷ and Gaurav Goyal, MD⁶

¹Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
²Department of Internal Medicine, University of Utah, Salt Lake City, UT
³Department of Infectious Disease, Creighton University, Omaha, NE
⁴University of Alabama at Birmingham, Birmingham, AL
⁵Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake CIty, UT
⁶Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁷Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸University of Alabama At Birmingham, Birmingham, AL
⁹Department of Infectious Diseases, University of Utah, Salt Lake City, UT

Joshua P P. Entrop^1*, Caroline E. Weibull, MSc, PhD^1*, Karin E. Smedby, MD, PhD^2,3*, Lasse Hjort Jakobsen, MSc, PhD^4,5*, Andreas K. Oevlisen, MD^6*, Ingrid Glimelius, MD, PhD^7*, Anna Marklund, MD, PhD^8*, Thomas S. Larsen, MD, PhD^9*, Harald Holte, MD, PhD¹⁰, Alexander Fosså, MD, PhD^10*, Knut B. Smeland, MD, PhD^10*, Tarec Christoffer Christoffer El-Galaly, MD, DSc^3,6,11 and Sandra Eloranta, MSc, PhD^1*

¹Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
²Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
³Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁴Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
⁵Department of Mathematical Science, Aalborg University, Aalborg, Denmark
⁶Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
⁷Department of Immunology, Genetics, and Pathology, Clinical and Experimental Oncology, Uppsala University, Uppsala Akademiska Hospital, Uppsala, Sweden
⁸Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden
⁹Odense University Hospital, Odense, Denmark
¹⁰Department of Oncology, Oslo University Hospital, Oslo, Norway
¹¹Department of Hematology, Odense University Hospital, Odense, Denmark

David Sibon, MD, PhD^1,2*, Christian Gisselbrecht, MD³, Thierry Jo Molina, MD, PhD^4*, Vincent Camus, MD^5*, Olivier Casasnovas, MD^6*, Christian Recher, MD, PhD^7*, Nicolas Ketterer, MD⁸, Olivier Fitoussi, MD^9*, Karim Belhadj, MD^1*, Julie Bruneau, MD, PhD^4*, Marie Parrens, MD, PhD^10*, Jean-François Emile, MD, PhD^11*, Josette Briere, MD^12*, Bettina Fabiani, MD^13*, Thierry Fest, MD, PhD^14*, Herve Ghesquieres, MD, PhD^15*, Franck Morschhauser, MD, PhD^16*, Corinne Haioun, MD, PhD¹⁷, Thierry Lamy, MD, PhD¹⁸, Olivier Hermine, MD, PhD¹⁹, Steven Le Gouill, MD, PhD²⁰ and Jean-Philippe Jais, MD, PhD^21*

¹Lymphoid Malignancies Department, Henri Mondor University Hospital, Creteil, France
²Faculty of Medicine and Health, Campus Henri Mondor, Paris-Est Creteil University, Creteil, France
³Saint-Louis University Hospital, Paris, France
⁴Pathology Department, Necker University Hospital, Paris, France
⁵Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France
⁶Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
⁷Hematology Department, IUCT-ONCOPOLE, Toulouse, France
⁸Hematology Department, Clinique Bois-Cerf, Lausanne, Switzerland
⁹Service d’oncologie-hématologie-radiothérapie, Polyclinique Bordeaux-Nord, Bordeaux, France
¹⁰Department of Pathology, Bordeaux University Hospital, Bordeaux, France
¹¹Departement of Pathology, Hôpital Ambroise-paré, APHP, Boulogne, France
¹²Pathology Department, Henri Mondor University Hospital, Creteil, France
¹³Pathology Department, Saint-Antoine University Hospital, Paris, France
¹⁴Department of Biological Hematology, University Hospital of Rennes, Rennes, France
¹⁵Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
¹⁶Hematology Department, Lille University Hospital, Lille, France
¹⁷Lymphoid Malignancies Department, Henri Mondor University Hospital/Assistance Publique-Hôpitaux de Paris (AP-HP)/Université Paris-Est Créteil (UPEC), Creteil, France
¹⁸Department of Hematology, Rennes University Hospital, Rennes, France
¹⁹Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
²⁰Institut Curie Comprehensive Cancer Center, Paris, France
²¹Necker University Hospital, PARIS, France

Victoria A. Vardell, MD¹, Daniel A. Ermann, MD², Harsh Shah, DO³, Lindsey A. Fitzgerald, MD⁴, Boyu Hu, MD³ and Deborah M. Stephens, DO³

¹Department of Internal Medicine, University of Utah, Salt Lake City, UT
²Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
³Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁴Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake CIty, UT